ROBERT JOSEPH TIMKO
Pharmacy in West Chester, PA
License number
Pennsylvania RP033991R
Category
Pharmacy
Type
Pharmacist
Address
Address
West Chester, PA 19382
Personal information
See more information about ROBERT JOSEPH TIMKO at radaris.comName
Address
Phone
523 Plum St, Johnstown, PA 15901
624 Millers Ln, Pittsburgh, PA 15239
638 Stockton Cir, Ridley Park, PA 19078
465 Old York Rd, New Cumberlnd, PA 17070
404 Hidden Valley Rd, New Cumberlnd, PA 17070
Professional information
See more information about ROBERT JOSEPH TIMKO at trustoria.com
Pharmaceutical Compositions Using Thiazepine
Pharmaceutical Compositions Using Thiazepine
US Patent:
5948437, Sep 7, 1999
Filed:
May 28, 1997
Appl. No.:
8/864306
Inventors:
Bhavnish Vinod Parikh - Hockessin DE
Robert Joseph Timko - West Chester PA
William Joseph Addicks - Morgantown WV
Robert Joseph Timko - West Chester PA
William Joseph Addicks - Morgantown WV
Assignee:
Zeneca Limited
International Classification:
A61K 920
US Classification:
424464
Abstract:
The invention relates to sustained release formulations comprising 11-�4-�2-(2-hydroxyethoxy)ethyl!-1-piperazinyl!dibenzo�b,f! �1,4!thiazepine or a pharmaceutically acceptable salt thereof, to methods of treating psychotic states and hyperactivity utilizing the sustained release formulations and to a process for preparing the sustained release formulations.
Pharmaceutical Agents
Pharmaceutical Agents
US Patent:
5993859, Nov 30, 1999
Filed:
Jul 13, 1998
Appl. No.:
9/114225
Inventors:
Robert Joseph Timko - West Chester PA
Randy John Bradway - Downingtown PA
Arlene Clements - Turnersville NJ
Randy John Bradway - Downingtown PA
Arlene Clements - Turnersville NJ
Assignee:
Zeneca Limited - London
International Classification:
A61K 916, A61K 920, C07D20910
US Classification:
424497
Abstract:
The invention provides a pharmaceutical composition comprising a particular physical form of N-[4-[5-(cyclopentyloxycarbonyl)amino-1-methylindol-3-yl-methyl]-3-methoxy benzoyl]-2-methyl-benzenesulphonamide and polyvinylpyrrolidone. It also provides methods for preparing this physical form, and another physical form of N-[4-[5-(cyclopentyloxycarbonyl)amino-1-methylindol-3-yl-methyl]-3-methoxy benzoyl]-2-methylbenzenesulphonamide useful in the preparation of the first mentioned physical form. The compositions are useful in the treatment of diseases in which leukotrienes are implicated, for example asthma.
Pharmaceutical Agents Useful As Leukotriene Antagonists
Pharmaceutical Agents Useful As Leukotriene Antagonists
US Patent:
5482963, Jan 9, 1996
Filed:
Sep 3, 1993
Appl. No.:
8/116781
Inventors:
James J. Holohan - Macclesfield, GB2
Ieuan J. Edwards - Congleton, GB2
Robert J. Timko - West Chester PA
Randy J. Bradway - Downingtown PA
Arlene Clements - Turnersville NJ
Ieuan J. Edwards - Congleton, GB2
Robert J. Timko - West Chester PA
Randy J. Bradway - Downingtown PA
Arlene Clements - Turnersville NJ
Assignee:
Zeneca Limited - London
International Classification:
A61K 3140, C07D20912
US Classification:
514415
Abstract:
The invention provides a pharmaceutical composition comprising a particular physical form of N-[4-[5-(cyclopentyloxycarbonyl)amino-1-methylindol-3-yl-methyl]-3-methoxy benzoyl]-2-methylbenzenesulphonamide and polyvinylpyrrolidone. It also provides methods for preparing this physical form, and another physical form of N-[4-[5-(cyclopentyloxycarbonyl)amino-1-methylindol-3-yl-methyl]-3-methoxy benzoyl]-2-methylbenzenesulphonamide useful in the preparation of the first mentioned physical form. The compositions are useful in the treatment of diseases in which leukotrienes are implicated, for example asthma.
Method Of Enhancing Bioavailability Of Pharmaceutical Agents
Method Of Enhancing Bioavailability Of Pharmaceutical Agents
US Patent:
5612367, Mar 18, 1997
Filed:
Jun 7, 1995
Appl. No.:
8/474191
Inventors:
Robert J. Timko - West Chester PA
Randy J. Bradway - Downingtown PA
Arlene Clements - Turnersville NJ
Randy J. Bradway - Downingtown PA
Arlene Clements - Turnersville NJ
Assignee:
Zeneca Limited - London
International Classification:
A61K 3140
US Classification:
514415
Abstract:
The invention provides a pharmaceutical composition comprising a particular physical form of N-[4-[5-(cyclopentyloxycarbonyl)amino-1-methylindol-3-yl-methyl]-3-methoxy benzoyl]-2-methylbenzenesulphonamide and polyvinylpyrrolidone. It also provides methods for preparing this physical form, and another physical form of N-[4-[5-(cyclopentyloxycarbonyl)amino-1-methylindol-3-yl-methyl]-3-methoxy benzoyl]-2-methylbenzenesulphonamide useful in the preparation of the first mentioned physical form. The compositions are useful in the treatment of diseases in which leukotrienes are implicated, for example asthma.